FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 03/16/23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATEPRNewsWire • 03/13/23
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATEPRNewsWire • 03/11/23
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 03/04/23
Fate Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business UpdatesGlobeNewsWire • 02/28/23
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 02/25/23
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 02/18/23
Fate Class Action: Levi & Korsinsky Reminds Fate Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 22, 2023 - FATENewsfile Corp • 02/16/23
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Fate Therapeutics (FATE) Investors to Securities Class Action, Encourages Investors with Significant Losses to Contact Firm's AttorneysNewsfile Corp • 02/15/23
Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewsWire • 02/13/23
ALERT: Investors in Fate Therapeutics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FATENewsfile Corp • 02/11/23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATENewsfile Corp • 02/10/23
FATE CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm's Attorneys, Securities Class Action PendingNewsfile Corp • 02/09/23
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (FATE)Newsfile Corp • 02/09/23
Fate Therapeutics Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More InformationNewsfile Corp • 02/08/23
FATE INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm's Attorneys, Securities Class Action FiledNewsfile Corp • 02/07/23
Wall Street Analysts Believe Fate Therapeutics (FATE) Could Rally 172.49%: Here's is How to TradeZacks Investment Research • 02/06/23
ROSEN, A LONGSTANDING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 02/05/23
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATENewsfile Corp • 02/03/23
Fate Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 22, 2023 to Discuss Your Rights - FATENewsfile Corp • 02/03/23
HAGENS BERMAN Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Lawsuit PendingNewsfile Corp • 02/02/23
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Fate Therapeutics, Inc. (FATE) Investors and Encourages Investors to Contact the Firm Before March 22, 2023Business Wire • 02/02/23
